Cidara Therapeutics - Stock Price History | CDTX
Historical daily share price chart and data for Cidara Therapeutics since 2023 adjusted for splits. The latest closing stock price for Cidara Therapeutics as of January 27, 2023 is 1.21.
- The all-time high Cidara Therapeutics stock closing price was 17.26 on December 30, 2015.
- The Cidara Therapeutics 52-week high stock price is 1.60, which is 32.2% above the current share price.
- The Cidara Therapeutics 52-week low stock price is 0.40, which is 66.9% below the current share price.
- The average Cidara Therapeutics stock price for the last 52 weeks is 0.69.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cidara Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
0.6878 |
1.3900 |
1.3900 |
0.4280 |
0.7563 |
-40.45% |
| 2021 |
2.0042 |
2.0600 |
3.0100 |
1.1800 |
1.2700 |
-36.50% |
| 2020 |
3.0633 |
3.4100 |
4.2600 |
1.7400 |
2.0000 |
-47.92% |
| 2019 |
2.1910 |
2.7000 |
3.8400 |
1.2500 |
3.8400 |
63.40% |
| 2018 |
4.8665 |
6.9500 |
8.1500 |
2.1000 |
2.3500 |
-65.44% |
| 2017 |
7.5928 |
10.1500 |
11.7000 |
5.7500 |
6.8000 |
-34.62% |
| 2016 |
11.3948 |
16.9300 |
16.9300 |
8.7000 |
10.4000 |
-39.39% |
| 2015 |
14.8686 |
16.0000 |
17.2600 |
12.4300 |
17.1600 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.087B |
$0.050B |
|
Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
|
